HUYABIO Bioscience International is a pioneering brand that is revolutionizing the global biopharmaceutical industry by harnessing the power of Chinese innovation. With a network of eight offices equipped with highly skilled scientists across China, HUYABIO boasts the largest compound portfolio covering all major therapeutic areas. Spearheaded by the visionary President & CEO, Mireille Gillings, PhD, Hon DSc, the company's mission is to unlock the immense potential of therapeutic opportunities from Chinese institutes and universities, making them accessible worldwide.

Their teams in San Diego, Tokyo, Dublin, Montreal, Seoul, and China are steadfast in building strong collaborations and leveraging diverse approaches such as in-licensing, alliances, and research funding to propel China's groundbreaking healthcare discoveries into the global market. HUYABIO is dedicated to addressing tomorrow's unmet medical needs by empowering Chinese researchers and facilitating the advancement of their breakthroughs. Trust HUYABIO to bring China's healthcare discoveries to enrich lives across the globe